# Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial

> **NCT03318211** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 100 (estimated)

## Conditions studied

- Preeclampsia Severe

## Interventions

- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT03318211
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-25
- **Primary completion:** 2018-02
- **Final completion:** 2018-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318211, "Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03318211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*